Prevalence of Musculoskeletal Pain and Its Impact on Quality of Life and Functional Exercise Capacity in Patients With Pulmonary Arterial Hypertension
1 other identifier
observational
61
1 country
1
Brief Summary
Prevalence of musculoskeletal pain and its impact of quality of life and functional exercise capacity will be evaluated in patients with pulmonary arterial hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 18, 2021
CompletedFirst Posted
Study publicly available on registry
March 22, 2021
CompletedStudy Start
First participant enrolled
March 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2021
CompletedJune 18, 2021
June 1, 2021
3 months
March 18, 2021
June 17, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
The Nordic Musculoskeletal Questionnaire
The Nordic Musculoskeletal Questionnaire will be used to evaluate musculoskeletal pain prevalence.
At baseline
Secondary Outcomes (4)
The EmPHasis-10 questionnaire
At baseline
The Minnesota Living with Heart Failure Questionnaire
At baseline
6-min walk distance
At baseline
International Physical Activity Questionnaire - Short Form
At baseline.
Study Arms (1)
Pulmonary arterial hypertension
Adult patients with pulmonary arterial hypertension
Interventions
Prevalence of musculoskeletal pain will be evaluated over 9 body regions using The Nordic Musculoskeletal Questionnaire.
Quality of life will be evaluated using The EmPHasis-10 questionnaire and The Minnesota Living with Heart Failure Questionnaire.
Functional exercise capacity will be evaluated using 6-min walk test.
Physical activity level will be evaluated using International Physical Activity Questionnaire- Short Form
Eligibility Criteria
Adult patients diagnosed with pulmonary arterial hypertension
You may qualify if:
- Diagnosis of pulmonary arterial hypertension
You may not qualify if:
- Diagnosis of heart failure or any chronic respiratory disease
- Recent coronary bypass surgery
- Recent acute myocardial infarction
- Having a pacemaker
- Having any orthopedic or neurologic diseases which may impede walking or exercising
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Izmir Bakircay Universitylead
- Istanbul University - Cerrahpasacollaborator
Study Sites (1)
Istanbul University-Cerrahpasa, Institute of Cardiology
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assist. Prof. Dr.
Study Record Dates
First Submitted
March 18, 2021
First Posted
March 22, 2021
Study Start
March 25, 2021
Primary Completion
June 15, 2021
Study Completion
June 15, 2021
Last Updated
June 18, 2021
Record last verified: 2021-06